Plant Vesicle Nucleic Acid Carrier for Reproducible Cell Uptake

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current drug delivery systems (DDS) for nucleic acid reagents such as siRNAs, shRNAs, and miRNAs lack a carrier that can reproducibly facilitate the uptake of nucleic acids into cells.

Innovation Solution

A carrier for nucleic acids comprising vesicles derived from plant fruits, particularly from plants in the families Malpighiaceae and Rutaceae, which form a conjugate with the nucleic acids, enabling easy uptake into cells through endocytosis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional drug delivery systems are used for nucleic acid reagents, then the nucleic acids can be delivered to cells, but the uptake of nucleic acids into cells is not reproducible and efficiency is low

Engineering Contradiction:
Improvereproducibility of nucleic acid uptakeVSAvoiduptake efficiency of nucleic acid into cells
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent uses plant fruit vesicles as an intermediary carrier to facilitate the delivery of nucleic acid reagents into cells. The vesicles act as a mediator that bridges the nucleic acid and the cell membrane, enabling reproducible and efficient uptake through endocytosis without requiring complex chemical modifications or transfection reagents

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of operation

If no carrier is used for nucleic acid delivery, then the system is simple, but the nucleic acids cannot be effectively introduced into cells

Engineering Contradiction:
Improvesimplicity of delivery systemVSAvoideffectiveness of nucleic acid introduction
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The plant fruit vesicles possess inherent properties that enable them to self-assemble with nucleic acids and self-deliver into cells through natural endocytic pathways. This self-service mechanism eliminates the need for complex external delivery systems while maintaining simplicity and high effectiveness simultaneously

Inventive Principle:
Principle #25Self-service

3Device complexity

If nucleic acids are administered without a carrier, then the administration process is simple, but the nucleic acids are degraded and cannot function within cells

Engineering Contradiction:
Improvecomplexity of administration systemVSAvoidstability of nucleic acid
Core Design Contradiction:
Device complexityVSStability of the object's composition

Solution Approach 1:

The plant fruit vesicles provide a flexible membrane structure that encapsulates and protects nucleic acid reagents from degradation. The vesicular membrane acts as a protective barrier while remaining flexible enough to facilitate cellular uptake, thereby maintaining both simplicity and stability

Inventive Principle:
Principle #30Flexible shells and thin films

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The vesicle-based carrier effectively holds and introduces nucleic acids into cells, preventing degradation and allowing the nucleic acids to function within the cells, making it useful for gene therapy and other applications.

Implementation Method 1

the carrier for a nucleic acid and the nucleic acid form a conjugate

Methodology Applied
Scientific EffectConjugate formation: Adsorption

Implementation Method 2

can introduce the thus held nucleic acid into cells through endocytosis

Methodology Applied
Scientific EffectEndocytosis:

Implementation Method 3

preventing degradation and allowing the nucleic acids to function within the cells

Methodology Applied
Scientific EffectProtection from degradation:

Data Source

PatentUS12508326B2Nucleic acid carrier and method for administering nucleic acid
Publication Date: 2025.12.30 TOKYO MEDICAL UNIVERSITY
  • US12508326B2 patent drawing
  • US12508326B2 patent drawing
  • US12508326B2 patent drawing

AI summary

Provided is a novel carrier for introducing a nucleic acid such as a siRNA into a cell. The carrier for a nucleic acid of the present invention includes vesicles from a plant in the family Malpighiaceae, and preferably vesicles derived from acerola. A method for administering a nucleic acid according to the present invention includes forming a conjugate of the carrier for a nucleic acid of the present invention and a nucleic acid and administering the conjugate.